Death-associated Protein Kinase 1 is Associated with Cognitive Dysfunction in Major Depressive Disorder

Overview

Journal Neural Regen Res

Date 2023 Feb 8

PMID 36751808

Authors

Xiao-Hui Li

Hong-Can Zhu

Xue-Min Cui

Wang Wang

Lin Yang

Li-Bo Wang

Neng-Wei Hu

Dong-Xiao Duan

Affiliations

Soon will be listed here.

Abstract

We previously showed that death-associated protein kinase 1 (DAPK1) expression is increased in hippocampal tissue in a mouse model of major depressive disorde and is related to cognitive dysfunction in Alzheimer's disease. In addition, depression is a risk factor for developing Alzheimer's disease, as well as an early clinical manifestation of Alzheimer's disease. Meanwhile, cognitive dysfunction is a distinctive feature of major depressive disorder. Therefore, DAPK1 may be related to cognitive dysfunction in major depressive disorder. In this study, we established a mouse model of major depressive disorder by housing mice individually and exposing them to chronic, mild, unpredictable stressors. We found that DAPK1 and tau protein levels were increased in the hippocampal CA3 area, and tau was hyperphosphorylated at Thr231, Ser262, and Ser396 in these mice. Furthermore, DAPK1 shifted from axonal expression to overexpression on the cell membrane. Exercise and treatment with the antidepressant drug citalopram decreased DAPK1 expression and tau protein phosphorylation in hippocampal tissue and improved both depressive symptoms and cognitive dysfunction. These results indicate that DAPK1 may be a potential reason and therapeutic target of cognitive dysfunction in major depressive disorder.

Citing Articles

Peripheral mitochondrial DNA as a neuroinflammatory biomarker for major depressive disorder.

Ye J, Duan C, Han J, Chen J, Sun N, Li Y Neural Regen Res. 2024; 20(6):1541-1554.

PMID: 38934398 PMC: 11688552. DOI: 10.4103/NRR.NRR-D-23-01878.

End-stage renal disease accompanied by mild cognitive impairment: A study and analysis of trimodal brain network fusion.

Chen J, Liu T, Shi H PLoS One. 2024; 19(6):e0305079.

PMID: 38870175 PMC: 11175492. DOI: 10.1371/journal.pone.0305079.

Death-associated protein kinase 1 as a therapeutic target for Alzheimer's disease.

Zhang T, Kim B, Lee T Transl Neurodegener. 2024; 13(1):4.

PMID: 38195518 PMC: 10775678. DOI: 10.1186/s40035-023-00395-5.

Ventral tegmental area dopaminergic circuits participates in stress-induced chronic postsurgical pain in male mice.

Liu W, Wang W, Wang Z, Xing Y BMC Neurosci. 2024; 25(1):3.

PMID: 38195391 PMC: 10775611. DOI: 10.1186/s12868-023-00842-z.

References

Agnihotri A, Aruoma O . Alzheimer's Disease and Parkinson's Disease: A Nutritional Toxicology Perspective of the Impact of Oxidative Stress, Mitochondrial Dysfunction, Nutrigenomics and Environmental Chemicals. J Am Coll Nutr. 2019; 39(1):16-27. DOI: 10.1080/07315724.2019.1683379. View

Xu Y, Wang Q, Wu Z, Lu K, Cheng X, Jin W . The effect of lithium chloride on the attenuation of cognitive impairment in experimental hypoglycemic rats. Brain Res Bull. 2019; 149:168-174. DOI: 10.1016/j.brainresbull.2019.04.019. View

Shih H, Lin C, Tu Y, Chang C, Hsu H, Chi C . An increased risk of reversible dementia may occur after zolpidem derivative use in the elderly population: a population-based case-control study. Medicine (Baltimore). 2015; 94(17):e809. PMC: 4603066. DOI: 10.1097/MD.0000000000000809. View

Beharry C, Cohen L, Di J, Ibrahim K, Briffa-Mirabella S, Alonso A . Tau-induced neurodegeneration: mechanisms and targets. Neurosci Bull. 2014; 30(2):346-58. PMC: 5562659. DOI: 10.1007/s12264-013-1414-z. View

Gu C, He H, Duan H, Su Z, Chen H, Gan J . Predictors of neurocognitive impairment at 2years after a first-episode major depressive disorder. Compr Psychiatry. 2016; 68:24-33. DOI: 10.1016/j.comppsych.2016.03.009. View

Hou Y, Aboukhatwa M, Lei D, Manaye K, Khan I, Luo Y . Anti-depressant natural flavonols modulate BDNF and beta amyloid in neurons and hippocampus of double TgAD mice. Neuropharmacology. 2009; 58(6):911-20. PMC: 2838959. DOI: 10.1016/j.neuropharm.2009.11.002. View

Schmitter M, Spijker J, Smit F, Tendolkar I, Derksen A, Oostelbos P . Exercise enhances: study protocol of a randomized controlled trial on aerobic exercise as depression treatment augmentation. BMC Psychiatry. 2020; 20(1):585. PMC: 7724825. DOI: 10.1186/s12888-020-02989-z. View

Kim S, Choe K, Lee K . Depression, Loneliness, Social Support, Activities of Daily Living, and Life Satisfaction in Older Adults at High-Risk of Dementia. Int J Environ Res Public Health. 2020; 17(24). PMC: 7767125. DOI: 10.3390/ijerph17249448. View

Ouanounou A, Ng K . Medical management, orofacial findings, and dental care for the client with major depressive disorder. Can J Dent Hyg. 2020; 53(3):172-177. PMC: 7533804. View

10.

Kim N, Chen D, Zhou X, Lee T . Death-Associated Protein Kinase 1 Phosphorylation in Neuronal Cell Death and Neurodegenerative Disease. Int J Mol Sci. 2019; 20(13). PMC: 6651373. DOI: 10.3390/ijms20133131. View

11.

Lavretsky H, Laird K, Krause-Sorio B, Heimberg B, Yeargin J, Grzenda A . A Randomized Double-Blind Placebo-Controlled Trial of Combined Escitalopram and Memantine for Older Adults With Major Depression and Subjective Memory Complaints. Am J Geriatr Psychiatry. 2019; 28(2):178-190. PMC: 6997044. DOI: 10.1016/j.jagp.2019.08.011. View

12.

Bortolato B, Carvalho A, Soczynska J, Perini G, McIntyre R . The Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific Treatments. Curr Neuropharmacol. 2015; 13(5):558-76. PMC: 4761629. DOI: 10.2174/1570159x13666150630171433. View

13.

Reed M, Vanicek T, Seiger R, Klobl M, Spurny B, Handschuh P . Neuroplastic effects of a selective serotonin reuptake inhibitor in relearning and retrieval. Neuroimage. 2021; 236:118039. PMC: 7610799. DOI: 10.1016/j.neuroimage.2021.118039. View

14.

Guo S, Huang Y, Zhang Y, Huang H, Hong S, Liu T . Impacts of exercise interventions on different diseases and organ functions in mice. J Sport Health Sci. 2020; 9(1):53-73. PMC: 6943779. DOI: 10.1016/j.jshs.2019.07.004. View

15.

Du Preez A, Onorato D, Eiben I, Musaelyan K, Egeland M, Zunszain P . Chronic stress followed by social isolation promotes depressive-like behaviour, alters microglial and astrocyte biology and reduces hippocampal neurogenesis in male mice. Brain Behav Immun. 2020; 91:24-47. DOI: 10.1016/j.bbi.2020.07.015. View

16.

Reddy A, Yin X, Sawant N, Reddy P . Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer's disease. Hum Mol Genet. 2021; 30(10):847-864. PMC: 8355469. DOI: 10.1093/hmg/ddab054. View

17.

Liu J, Xu X, Zhu C, Luo L, Wang Q, Xiao B . Disrupted Structural Brain Network Organization Behind Depressive Symptoms in Major Depressive Disorder. Front Psychiatry. 2020; 11:565890. PMC: 7538511. DOI: 10.3389/fpsyt.2020.565890. View

18.

Lesuis S, Hoeijmakers L, Korosi A, de Rooij S, Swaab D, Kessels H . Vulnerability and resilience to Alzheimer's disease: early life conditions modulate neuropathology and determine cognitive reserve. Alzheimers Res Ther. 2018; 10(1):95. PMC: 6145191. DOI: 10.1186/s13195-018-0422-7. View

19.

Riancho J, Berciano M, Berciano J, Lafarga M . Relaunching an old drug: the potential role of bexarotene in neurodegenerative diseases. J Neurol. 2016; 263(1):177-8. DOI: 10.1007/s00415-015-8004-0. View

20.

Darcet F, Gardier A, Gaillard R, David D, Guilloux J . Cognitive Dysfunction in Major Depressive Disorder. A Translational Review in Animal Models of the Disease. Pharmaceuticals (Basel). 2016; 9(1). PMC: 4812373. DOI: 10.3390/ph9010009. View